Medical Technology IP Seminar
This seminar has ended. If you have questions about next year's Medical Technology IP Seminar, or about our other seminars, please email firstname.lastname@example.org.
After much success, BSKB is bringing back the Medical Technology IP Seminar for 2023. This seminar covers patent issues in the medical technology and healthcare fields. We will discuss recent developments at the Court of Appeals for the Federal Circuit and the US Supreme Court and their effect on obtaining patent rights for medical technology.
The seminar will not cover patenting of inventions relating to pharmaceutical products but instead will focus on medical related inventions that have a significant electronic, imaging, mechanical, chemical and biotechnological component to the invention.
For this year’s seminar, we will be discussing important court decisions from the past year in the field of medical technology. In particular, the U.S. Supreme Court in Amgen v. Sanofi examined what the standard should be for patents to be enabled. In addition, Best Medical International, Inc. v. Elekta Inc. (Fed. Cir. August 26, 2022) relates to experts and the level of skill in the art in a case relating to radiation therapy of tumors. Furthermore, we will turn to the Patent Trial and Appeal Board to consider obviousness issues in OsteoMed LLC v. Stryker European Operations Holdings LLC, relating to a bone plate patent, and Alcon Inc. v. AMO Development LLC, relating to cataract surgery patents. Still further, we will discuss Sanofi-Aventis Deutschland GMBH, v. Mylan Pharmaceuticals Inc., which discusses analogous art relating to a drug delivery device.
Moving outside of patent law, we will also discuss how copyright law can be applied to medical devices in Medical Imaging & Technology Alliance v. Library of Congress from the U.S. District Court for the District of Columbia.
The seminar will be hosted on Zoom from 9:30 am to 11:30 am on October 12, 2023 (JST). Zoom link is provided upon registration. The seminar will have native English speakers and native Japanese speakers; each lecturer being an attorney, U.S. patent agent or Japanese benrishi. English and Japanese language slides will be provided before the lecture.
For registration information, please contact email@example.com